-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We cut our target to $620, 37.8x our 2027 EPS estimate, below IDXX's historical forward P/E averages. We reduce our 2026 EPS view to $14.67 from $14.73 and keep our 2027 view at $16.42. We think the company is entering a transitional period marked by leadership change while the uncertainty in the current economic environment may constrain veterinary visits and pet owners' spend. In January 2026, the company announced that Michael Erickson, who has been with IDXX since 2011, will assume the role of President and CEO on May 12, 2026, succeeding the long-tenured CEO Jay Mazelsky, who will move to Executive Chair before retiring in May 2027. While pet owners continue to prioritize their companion animals' health, with pet-care costs rising above inflation in recent years, we think the focus may shift to essential visits only if inflationary pressures persist. The company will host its Q1 analyst call on May 12, when we expect to hear more on the near-term outlook and pet-care cost trends impacting IDXX.